Search

Your search keyword '"Gandjbakhch, Estelle"' showing total 623 results

Search Constraints

Start Over You searched for: Author "Gandjbakhch, Estelle" Remove constraint Author: "Gandjbakhch, Estelle"
623 results on '"Gandjbakhch, Estelle"'

Search Results

2. Abatacept/Ruxolitinib and Screening for Concomitant Respiratory Muscle Failure to Mitigate Fatality of Immune-Checkpoint Inhibitor Myocarditis.

3. PFMG2025–integrating genomic medicine into the national healthcare system in France

4. Systematic analysis of SCN5A variants associated with inherited cardiac diseases

5. Clinical impact of genetic testing in a large cohort of pediatric cardiomyopathies

6. Temporal trends in population characteristics and type of device among primary prevention implantable cardioverter defibrillator recipients: The DAI-PP programme

8. Management of conduction disease and arrhythmias in patients with cardiac amyloidosis: A position paper from the Working Group of Cardiac Pacing and Electrophysiology of the French Society of Cardiology

9. Abstract 4142400: Clinical implication and potential role of immunosuppression for myocarditis episodes in patients with desmoplakin cardiomyopathy: hope from the DSP-ERADOS Network?

10. Distinct Substrates of Idiopathic Ventricular Fibrillation Revealed by Arrhythmia Characteristics on Implantable Cardioverter-Defibrillator

11. Mode and Characteristics of Arrhythmia Initiation in Idiopathic Ventricular Fibrillation: A THESIS Substudy

12. Systematic analysis of drug-associated myocarditis reported in the World Health Organization pharmacovigilance database.

14. Long-Term Arrhythmic Follow-Up and Risk Stratification of Patients With Desmoplakin-Associated Arrhythmogenic Right Ventricular Cardiomyopathy

16. Position paper on sustainability in cardiac pacing and electrophysiology from the Working Group of Cardiac Pacing and Electrophysiology of the French Society of Cardiology

17. Proposed diagnostic criteria for arrhythmogenic cardiomyopathy: European Task Force consensus report

18. Rationale and design of the ARAMIS trial: Anakinra versus placebo, a double blind randomized controlled trial for the treatment of acute myocarditis

20. Rapid ventricular tachycardia in patients with tetralogy of Fallot and implantable cardioverter-defibrillator: Insights from the DAI-T4F nationwide registry

22. Androgenic Effects on Ventricular Repolarization: A Translational Study From the International Pharmacovigilance Database to iPSC-Cardiomyocytes.

23. Sex Differences in Outcomes of Tetralogy of Fallot Patients With Implantable Cardioverter-Defibrillators

24. Malignant Purkinje ectopy induced by sodium channel blockers

25. Lack of early etiologic investigations in young sudden cardiac death

28. Sex differences in the origin of Purkinje ectopy-initiated idiopathic ventricular fibrillation

29. Arrhythmia-induced cardiomyopathy: A potentially reversible cause of refractory cardiogenic shock requiring venoarterial extracorporeal membrane oxygenation

33. Prognostic value of ventricular arrhythmia in early post-infarction left ventricular dysfunction: the French nationwide WICD-MI study.

34. Position paper concerning the competence, performance and environment required for the practice of ablation in children and in congenital heart disease

35. Joint Position Paper of the Working Group of Pacing and Electrophysiology of the French Society of Cardiology and the French Society of Diagnostic and Interventional Cardiac and Vascular Imaging on magnetic resonance imaging in patients with cardiac electronic implantable devices

36. Mode and Characteristics of Arrhythmia Initiation in Idiopathic Ventricular Fibrillation

37. Clinical differences between drug‐induced type 1 Brugada pattern and syndrome

38. Clinical impact of post-mortem genetic testing in cardiac death and cardiomyopathy

40. Low rates of immediate coronary angiography among young adults resuscitated from sudden cardiac arrest

42. Safety of pulsed field ablation in more than 17,000 patients with atrial fibrillation in the MANIFEST-17K study

43. Proposed diagnostic criteria for arrhythmogenic cardiomyopathy:European Task Force consensus report

44. A novel tool for arrhythmic risk stratification in desmoplakin gene variant carriers

45. Long-Term Arrhythmic Follow-Up and Risk Stratification of Patients With Desmoplakin-Associated Arrhythmogenic Right Ventricular Cardiomyopathy

47. Flecainide to Prevent Atrial Arrhythmia After Patent Foramen Ovale Closure: AFLOAT Study, A Randomized Clinical Trial

50. NEXN Gene in Cardiomyopathies and Sudden Cardiac Deaths: Prevalence, Phenotypic Expression, and Prognosis

Catalog

Books, media, physical & digital resources